Commission Implementing Decision (EU) 2018/1622 of 29 October 2018 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the CouncilText with EEA relevance.

Commission Implementing Decision (EU) 2018/1622 of 29 October 2018 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products OJ L 167, 27.6.2012, p. 1. , and in particular the third subparagraph of Article 89(1) thereof, Whereas: (1) Commission Delegated Regulation (EU) No 1062/2014 Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294, 10.10.2014, p. 1). , as amended by Delegated Regulation (EU) 2017/698 Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (OJ L 103, 19.4.2017, p. 1). , establishes in its Annex II a list of active substance/product-type combinations included in the review programme of existing active substances in biocidal products on 3 February 2017. (2) For a number of active substance/product-type combinations included in that list, all the participants have withdrawn their support in a timely manner. (3) As regards some active substances generated in situ, the name of those active substances and their precursors which are supported in the review programme has been clarified in a more precise manner. This has lead in certain cases to a redefinition of the active substance in accordance with Article 13 of Delegated Regulation (EU) No 1062/2014. (4) A notification was published inviting persons wishing to support those active substance/product-types combinations which have been redefined and currently not supported, including the generation in situ of the active substances for the product-types listed in Annex II to Delegated Regulation (EU) No 1062/2014, so that the role of participant may be taken over. (5) For some active substance/product-type combinations no notification has been submitted or a notification has been submitted and rejected pursuant to paragraphs 4 or 5 of Article 17 of Delegated Regulation (EU) No 1062/2014. (6) In accordance with Article 20 of Delegated Regulation (EU) No 1062/2014, those active substance/product-type combinations should not be approved for use in biocidal products. (7) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS DECISION:

Article 1

The active substances listed in the Annex are not approved for the product-types indicated therein.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. Done at Brussels, 29 October 2018. For the Commission The President Jean-Claude Juncker

Annex

ANNEX Active substance/product type combinations not approved, including any nanomaterial forms: the generation in situ of the active substances for the product-types listed in Annex II to Delegated Regulation (EU) No 1062/2014, except when the active substance is generated from the precursor(s) mentioned in the entry of the table of that Annex for the concerned active substance/product-type combinations; the substance/product-type combinations listed in the table below, including any generation in situ of these substances using any precursor that is not mentioned in Annex II to Delegated Regulation (EU) No 1062/2014: Entry Number in Annex II to Delegated Regulation (EU) No 1062/2014Substance nameRapporteur Member StateEC numberCAS numberProduct-type(s)60Citric acidBE201-069-177-92-91172Cetylpyridinium ChlorideUK204-593-9123-03-52195Sodium 2-biphenylateES205-055-6132-27-41, 2, 3288N-(Dichlorofluoromethylthio)-N′,N′-dimethyl-N-phenylsulfamide (Dichlofluanid)UK214-118-71085-98-97365Pyridine-2-thiol 1-oxide, sodium salt (Sodium pyrithione)SE223-296-53811-73-23401SilverSE231-131-37440-22-49405Sulphur dioxideDE231-195-27446-09-54424Sodium bromideNL231-599-97647-15-62, 11, 12458Ammonium sulphateUK231-984-17783-20-211,121016Silver chlorideSE232-033-37783-90-610, 11515Ammonium bromideSE235-183-812124-97-911, 12526Potassium 2-biphenylateES237-243-913707-65-86, 9, 10, 13529Bromine chlorideNL237-601-413863-41-711541Sodium p-chloro-m-cresolateFR239-825-815733-22-91, 2, 3, 6, 9, 13609Mixture of cis- and trans-p-menthane-3,8 diol (Citriodiol)UKNot availableNot available19620Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) (THPS)MT259-709-055566-30-82673Didecyldimethylammonium chloride (DDAC (C8-10))IT270-331-568424-95-357856-(Phthalimido)peroxyhexanoic acid (PAP)IT410-850-8128275-31-03, 4 792Tetrachlorodecaoxide complex (TCDO)DE420-970-292047-76-21952Bacillus sphaericus other than Bacillus sphaericus 2362, strain ABTS-1743ITMicro-organism143447-72-718955Bacillus thuringiensis subsp.israelensis Serotype H14, other than strain AM65-52 and other than strain SA3AITMicro-organismNot available18957Bacillus subtilisDEMicro-organismNot available3939Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situSKMixtureNot available2, 3, 4, 5, 11, 12824Silver zinc zeoliteSENot available130328-20-051013Silver copper zeoliteSENot available130328-19-75835Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate (Esfenvalerate)PTPlant protection product66230-04-418